DSG3 and acquired polycythemia vera: Studies have proven that the clinical manifestation of PV is defined by the Dsg autoantibody profile, with mucosal PV presenting reactivity against Dsg3 and mucocutaneous PV against Dsg 1 and Dsg 3 [6].